Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane for Ischemia/Reperfusion Injury Protection
NCT00526695Phase 4Unknown
- Sponsor
- University of Zurich
- Start
- Jan 2005
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sevoflurane in ischemia-reperfusion injury (IRI), sponsored by University of Zurich. Status: unknown.
02
Drugs
sevoflurane
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT00526695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00526695.